Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Dana-Farber Cancer Institute
University of Pittsburgh
UNC Lineberger Comprehensive Cancer Center
MacroGenics
Arcus Biosciences, Inc.
Incyte Corporation
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
NGM Biopharmaceuticals, Inc
Region Skane
Revolution Medicines, Inc.
Labcorp Corporation of America Holdings, Inc
Stanford University
Purple Biotech Ltd.
Eli Lilly and Company
AstraZeneca
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Xencor, Inc.
Gene Surgery LLC
Cedars-Sinai Medical Center
Exelixis
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
Celldex Therapeutics
NextCure, Inc.
National Institutes of Health Clinical Center (CC)
Sumitomo Pharma America, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
Fate Therapeutics
Xencor, Inc.
Prelude Therapeutics
Herlev Hospital
Quadriga Biosciences, Inc.
Institut de Cancérologie de Lorraine
Ohio State University Comprehensive Cancer Center
Xencor, Inc.
Scripps Health
Ludwig Institute for Cancer Research
Incyte Corporation
Istituto Clinico Humanitas
Roswell Park Cancer Institute
AbbVie
Pfizer
Incyte Corporation
National Institutes of Health Clinical Center (CC)
University of Dundee